SWOG clinical trial number
CTSU/N0147

A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer

Closed
Phase
Published
Abbreviated Title
Colon Ph III oxaliplatin, 5-FU, leucovorin +/- cetuximab
Activated
08/01/2004
Closed
11/25/2009
Participants
CTSU

Research committees

Gastrointestinal Cancer

Treatment

5-Fluorouracil Irinotecan Leucovorin Calcium Oxaliplatin Cetuximab Atropine Sulfate Loperamide